Burrard Pharmaceuticals is a prominent supplier to the pharmaceutical industry, engaged in a wide array of services vital to drug development and manufacturing. The company specialises in providing comprehensive solutions that encompass analytical services, clinical trials management, contract development and manufacturing (CDMO), drug design, and drug development. With a keen focus on quality and efficiency, Burrard Pharmaceuticals also addresses the complexities of aseptic fill-finish processes, particularly for cytotoxic and high potency compounds, alongside lyophilisation and the production of various forms of parenterals, including both large and small volume preparations.

Services include:
– Analytical Services
– Clinical Trials Management
– Contract Development and Manufacturing (CDMO)
– Drug Design
– Drug Development
– Manufacturing
– Aseptic Fill-Finish
– Cytotoxic & High Potency Compounds
– Lyophilization
– Parenterals
– Large Volume
– Small Volume
– Powders
– Sterile
– Vaccines
– Technology Transfer
– Containment
– APIs (Active Pharmaceutical Ingredients)
– Protein and Peptide
– Solid Dosage
– Injectables
– Non Sterile Dosage
– Clinical Dose
– Packaging

Burrard Pharmaceuticals remains dedicated to facilitating the advancement of pharmaceutical innovations through its extensive service offerings. For more information, please visit burrardpharma.com.